logo

Merck & Co Inc. (MRK)



Trade MRK now with
  Date
  Headline
8/7/2019 2:08:35 AM AstraZeneca, Merck Announce Positive Results From Phase III PROfound Trial Of Lynparza
7/31/2019 6:47:50 AM Merck Says FDA Approves New Monotherapy Indication For KEYTRUDA
7/30/2019 7:41:29 AM Merck Lifts FY Adj. Profit View
7/30/2019 6:48:17 AM Merck Q2 GAAP EPS $1.03, Non-GAAP EPS $1.30
7/29/2019 4:14:45 PM Merck Receives Positive EU CHMP Opinion For ZERBAXA 3g Dose
7/29/2019 6:37:30 AM Merck: EMA Adopts Positive Opinion For KEYTRUDA In Combination With Inlyta
7/24/2019 11:09:38 AM Merck Announces Presentation Of Phase 2b Results For Investigational HIV-1 Therapy Islatravir
7/23/2019 1:42:56 PM Merck & Co Inc. (MRK) Declares $ 0.55 Dividend for Q4 19, Record Date 9/16/2019
7/23/2019 1:14:39 PM Merck Declares Quarterly Dividend Of $0.55/share, Payable Oct. 7/ Record Sept. 16
7/17/2019 6:50:06 AM Merck Says FDA Approves RECARBRIO